ALLO
Allogene Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD2.19
-0.03 (-1.35%)
Rating:C-
Company Profile
CEO
David D. Chang
IPO Date
2018-10-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$2.24
Prev. Close
$2.22
Day Low
$2.19
Day High
$2.25
52W Low
$0.98
52W High
$4.46
Market Cap
$0.53B
Volume
0.76M